APA (7th ed.) Citation

Eggemann, H., Ignatov, T., Burger, E., Kantelhardt, E. J., Fettke, F., Thomssen, C., . . . Ignatov, A. (2015). Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer. Endocrine-Related Cancer, 22(5), 725. https://doi.org/10.1530/ERC-15-0335

Chicago Style (17th ed.) Citation

Eggemann, Holm, Tanja Ignatov, Elke Burger, Eva Johanna Kantelhardt, Franziska Fettke, Christoph Thomssen, Serban Dan Costa, and Atanas Ignatov. "Moderate HER2 Expression as a Prognostic Factor in Hormone Receptor Positive Breast Cancer." Endocrine-Related Cancer 22, no. 5 (2015): 725. https://doi.org/10.1530/ERC-15-0335.

MLA (9th ed.) Citation

Eggemann, Holm, et al. "Moderate HER2 Expression as a Prognostic Factor in Hormone Receptor Positive Breast Cancer." Endocrine-Related Cancer, vol. 22, no. 5, 2015, p. 725, https://doi.org/10.1530/ERC-15-0335.